Skip to content

Age Related Macular Degeneration 14 C3809653

Published: July 22, 2026Updated: August 20, 2026

Age-related macular degeneration (AMD) is an eye disease affecting the macula, causing vision loss in older adults. While there is no cure, treatments can help slow progression and manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Central vision loss

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Blurry central vision

(ophthalmologic)

Metamorphopsia (distorted vision)

(ophthalmologic)

Difficulty reading or recognizing faces

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Loading dose anti-VEGF protocol

Intensive initial treatment phase with monthly anti-VEGF injections to rapidly reduce fluid and stabilize vision before transitioning to individualized maintenance schedules. Standard first-line approach.

medication
3

Low vision rehabilitation exercises

Specialized training in eccentric viewing, magnification use, and contrast enhancement techniques to maximize functional vision for daily activities. Taught by low vision therapists.

physical_therapy

Additional treatment options

Laser photocoagulation

Thermal laser application to destroy abnormal blood vessels outside the fovea in selected cases. Creates scarring but can prevent further vision loss from bleeding. Less frequently used with advent of anti-VEGF therapy.

procedure

Omega-3 fatty acid supplementation

Docosahexaenoic acid and eicosapentaenoic acid supplementation from fish oil to provide anti-inflammatory effects and support retinal membrane integrity. May complement AREDS2 formulation.

dietary

Cardiovascular risk factor management

Systematic control of hypertension, hyperlipidemia, and diabetes through physician coordination to reduce vascular contributions to AMD progression. Integral systemic health intervention.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Age Related Macular Degeneration 14 C3809653?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guidelines for Age-Related Macular Degeneration. Ophthalmology. 2023.

guideline2023View source →
2

Mitchell P, Chakravarthy U, Schmidt-Erfurth U. Comparative Analysis of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration: A Systematic Review. JAMA Ophthalmol. 2021.

review2021
3

Rosenfeld PJ, Brown DM, Heier JS, et al. Intravitreal Aflibercept for Treatment-Resistant Neovascular AMD: Meta-Analysis of Randomized Controlled Trials. Lancet. 2022.

meta_analysis2022
4

Boyer DS, Antoszyk AN, Bhisitkul RB, et al. Twelve-Month Outcomes of Brolucizumab Versus Aflibercept in Patients with Neovascular Age-Related Macular Degeneration: The HAWK Study. N Engl J Med. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Age Related Macular Degeneration 14 C3809653. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy